Arcutis Biotherapeutics, Inc.ARQTNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+265.1%
5Y CAGR+140.6%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+265.1%/yr
Annual compound
5Y CAGR
+140.6%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
80.6x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $36.70M | +91.8% |
| 2024 | $19.13M | +283.6% |
| 2023 | $4.99M | +561.4% |
| 2022 | $754000.00 | -1.2% |
| 2021 | $763000.00 | +67.7% |
| 2020 | $455000.00 | +133.3% |
| 2019 | $195000.00 | - |
| 2018 | $0.00 | - |
| 2017 | $0.00 | - |